facebooktwittersocial icons 6

Together We Can Make A Difference
For Those Affected By Sarcomas!

Study Registry

There is no translation available.

Taking part in a clinical trial can be a good choice but it is often hard to find a clinical trial that is right for you. Many patient organisations and websites maintain lists of clinical trials. The following table lists some of the clinical trials available worldwide. Please note: this is not an exhaustive list, so please check with your local patient organisation. Other trials may be available in your country. If you are aware of an open trial that should be listed here, please send us the trial information to: このメールアドレスはスパムボットから保護されています。閲覧するにはJavaScriptを有効にする必要があります。


GIST trials

Trial Name Subtype Results Agents Phase Status Sponsor
SSG XXII: 3 vs. 5 years of adjuvant imatinib Operable GIST Not available yet Imatinib III Open, recruiting Scandinavian Sarcoma Group (SSG)
Voyager Unresectable or metastatic GIST Not available yet Avapritinib vs. regorafenib III Open, recruiting Blueprint Medicines Corporation
Crenolanib GIST (D842V mutation) Not available yet Crenolanib vs. placebo in D842V mutated GIST III Open, recruiting Arog Pharmaceuticals, Inc.
INTRIGUE GIST Not available yet DCC-2618 (ripretinib) vs. sunitinib III Open, recruiting Deciphera Pharmaceuticals LLC
REGISTRI KIT/PDGFR wild type GIST Not available yet Regorafenib II Open, recruiting Grupo Espanol de Investigacion en Sarcomas
Mitigate GIST Not available yet A novel PET-CT tracer specifically developed to target cell surface receptors of GIST cells I/IIa Open, recruiting Medical University Innsbruck, European Union
Navigator GIST incl. D842V mutation Further information here Avapritinib (formerly BLU-285)  I Closed, active Blueprint Medicines Corporation
INVICTUS GIST, all types of KIT and PDGFRa mutations Further information see here DCC-2618 vs. placebo III Closed, active Deciphera Pharmaceuticals LLC
CABO-GIST GIST Further information here Cabozantinib II Closed, active EORTC
ALT-GIST GIST Not available yet Imatinib alternating with Regorafenib vs. Imatinib alone II Closed, active The Australasian Gastro-Intestinal Trials Group in collaboration with the EORTC


Sarcoma trials

Trial Name Subtype Results Agents Phase Status Sponsor
Selinexor in Advanced Liposarcoma (SEAL) Dedifferentiated Liposarcoma Phase II results available Selinexor II/III Open, recruiting Karyopharm Therapeutics
Cabozantinib in HGUtS High Grade Uterine Sarcoma Not availalble yet Cabozantinib II Open, recruiting EORTC
rEECur Ewing's sarcoma Not available yet Four different chemotherapy regimens II/III Open, recruiting University of Birmingham
Euro Ewing 2012 Ewing's sarcoma Not available yet Different chemotherapy regimens III Open, recruiting University of Birmingham

Spearhead 1

Advanced Synovial Sarcoma or Myxoid/Round Cell Liposarcoma Not available yet Gene therapy: ADP-A2M4 II Open, recruiting Adaptimmune
ANITA Soft Tissue Sarcoma Not available yet Nintedanib with Ifosfamide in advanced, metastatic Soft Tissue Sarcoma II Closed, active EORTC in collaboration with Boehringer Ingelheim
Trabectedin Maintenance Soft Tissue Sarcoma Not available yet Trabectedin Maintenance Post 1st-line in STS III Open, recruiting EORTC in collaboration with PharmaMar
Dose Reduction of Preoperative Radiotherapy in Myxoid Liposarcomas (DOREMY) Myxoid Liposarcoma Not available yet Preoperative Radiotherapy II Open, recruiting The Netherlands Cancer Center
REGOBONE Ewing's sarcoma, Chondrosarcomas, Osteosarcomas, Chondromas Not available yet Regorafenib vs. placebo II Open, recruiting (France only) UNICANCER
TAPPAS Angiosarcoma Not available yet TRC105 (carotuximab) + pazopanib vs. pazopanib alone III Terminated Tracon Pharmaceuticals Inc.


Desmoid tumours / Aggressive fibromatosis trials

Trial Name Subtype Results Agents Phase Status Sponsor
Nirogacestat in Desmoid Tumor/
Aggressive Fibromatosis
Desmoid Tumor/Aggressive Fibromatosis Not availalble yet Nirogacestat III Open, recruiting SpringWorks Therapeutics, Inc.
The Desmoid Tumour Research Foundation has a extensive list of further ongoing, mostly mono-country clinical trials for patients with desmoid tumour / aggressive fibromatosis. Please find it here.

Chordoma trials

The Chordoma Foundation has a extensive list of clinical trials designed specifically for chordoma patients, as well as other relevant trials recommended by the Chordoma Foundation’s MAB on their website. Please see for the clinical trials list here

Expanded access programms

An Expanded Access Program (EAP) allows physicians and patients access to pre-approval, investigational drugs outside of the clinical trial setting. An EAP can also be called a Managed Access Program (MAP), Early Access Program, or Compassionate Use Program (CUP).